France Alzheimer’s Disease Diagnostic Market – Advancing Early Detection and Biomarker-Based Assessment
The France Alzheimer’s Disease Diagnostic Market focuses on technologies and services used to evaluate cognitive decline and support the diagnosis or characterization of Alzheimer’s disease.
Alzheimer’s diagnosis can involve clinical assessment, cognitive testing, imaging, laboratory analysis, and increasingly biomarker-based approaches. Accurate evaluation can help...
0 Commentaires
0 Parts
77 Vue
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt